Skip to main content
Galapagos NV logo

Galapagos NV — Investor Relations & Filings

Ticker · GLPG ISIN · BE0003818359 LEI · 549300QKJ78IY0IOV655 BR Manufacturing
Open in API
Filings indexed 2,855 across all filing types
Latest filing 2026-05-07 Interim / Quarterly Rep…
Country BE Belgium
Listing BR GLPG

About Galapagos NV

https://www.glpg.com/

Galapagos NV is a biotechnology company focused on transforming patient outcomes through scientific innovation. The company is strategically concentrating its efforts on its cell therapy platform, which is engineered for the scalable, decentralized, and rapid production of next-generation treatments. A key feature of this platform is a median 7-day vein-to-vein delivery time. In parallel with this focus, Galapagos is actively seeking partners to take over its portfolio of small molecule assets, including its TYK2 inhibitor program for autoimmune indications. This strategic shift allows the company to prioritize the growth and development of its cell therapy pipeline through internal discovery, partnerships, and acquisitions.

Recent filings

Filing Released Lang Actions
Galapagos Reports First Quarter 2026 Financial Results and Provides Business Update
Interim / Quarterly Report Classification · 95% confidence The document is a detailed financial report from Galapagos for the first quarter of 2026, including comprehensive financial results, business updates, strategic transactions, and management commentary. It contains actual financial data such as revenues, expenses, net profit/loss, and cash balances, as well as detailed explanations of business developments and future guidance. The presence of quarterly financial statements and substantive financial analysis indicates this is an Interim / Quarterly Report. The document is about 15,000 characters long, which is consistent with a full report rather than a brief announcement or press release. Therefore, the appropriate classification is Interim / Quarterly Report (IR).
2026-05-07 English
Galapagos Reports First Quarter 2026 Financial Results and Provides Business Update
Interim / Quarterly Report Classification · 95% confidence The document is a detailed financial and business update from Galapagos for the first quarter of 2026. It includes comprehensive financial data such as revenues, costs, net profit/loss, and cash balances, as well as detailed discussion of business developments, strategic transactions, and outlook. The presence of actual financial statements and substantive financial analysis for a quarter indicates this is a quarterly financial report. The document also mentions a conference call scheduled to discuss these results, which is typical for quarterly reports. It is not merely an announcement or a brief summary, but a full report with detailed financial figures and business commentary. Therefore, the document fits the definition of an Interim / Quarterly Report (IR).
2026-05-07 English
6-K - GALAPAGOS NV (0001421876) (Filer)
Regulatory Filings
2026-05-06 English
6-K - GALAPAGOS NV (0001421876) (Filer)
Regulatory Filings
2026-04-29 English
Galapagos’ Shareholders Adopt All Resolutions Proposed by the Board of Directors at the Annual and Extraordinary Shareholders’ Meetings 2026
Declaration of Voting Results & Voting Rights Announcements Classification · 92% confidence The document is a press release announcing that all proposals at the Ordinary and Extraordinary General Meetings on 28 April 2026 were approved, listing each approved resolution (e.g., approval of the annual report, board appointments, share buyback authorisation, name change). This is a declaration of shareholder voting results at general meetings, matching the “Declaration of Voting Results & Voting Rights Announcements” category (DVA).
2026-04-29 Dutch
Galapagos’ Shareholders Adopt All Resolutions Proposed by the Board of Directors at the Annual and Extraordinary Shareholders’ Meetings 2026
Declaration of Voting Results & Voting Rights Announcements Classification · 88% confidence The document is an announcement from Galápagos summarizing the resolutions approved at its Annual and Extraordinary Shareholders’ Meetings held on 28 April 2026. It lists the items approved by shareholders (e.g., approval of the Annual Report and Remuneration Report, board appointments, name change, share acquisition authorization, capital renewal) and states that meeting minutes will follow. This is clearly a declaration of voting results from the shareholder meetings, matching the definition for Declaration of Voting Results & Voting Rights Announcements (Code: DVA).
2026-04-29 English

Browse filings by year

22 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.